Posted on Leave a comment

Payment method: Bank Transfer

Posted on Leave a comment

Regarding bank transfer, GDMeds, now, offer one more option – check local bank account first. To date, GDMeds has opened several bank accounts in different countries around the world. For the customer who chooses this option, GDMeds will offer the local bank account for the payment transfer if have. Compared with the international bank transfer,…

Read more

Posted on

Compare Harvoni vs. Epclusa

Posted on

Harvoni (ledipasvir / sofosbuvir) Myhep Lvir, Hepcinat, Ledihep, etc Epclusa (velpatasvir / sofosbuvir) Mylan All, Velpanat, Sovihep, Resof, etc. Treats hepatitis C. Harvoni (ledipasvir / sofosbuvir) is a combination pill for hepatitis C that you only need to take once a day. Depending on the amount of liver damage you have, it’s sometimes taken together…

Read more

Posted on

Four Treatment For Mastectomy Pain,But ‘No Magic Drug’.

Posted on

Postmastectomy pain syndrome is a “major clinical challenge,” but four treatment modalities have been found to have a “significant effect” on the pain, conclude the authors of a new review systematic review of the subject. However, another expert laid emphasis elsewhere, saying there is “no magic drug” and that some patients feel their ongoing, intractable…

Read more

Posted on

Aspirin Plus PPI Prevents Esophageal Cancer.

Posted on

Combined use of aspirin and a high-dose proton pump inhibitor (PPI) protects against the development of esophageal cancer in people who are at elevated risk for the malignancy, according to the results of a major phase 3 chemoprevention trial from the United Kingdom, the Aspirin and Esomeprazole Chemoprevention in Barrett’s Metaplasia (AspECT) trial. Dr Janusz…

Read more

Posted on

Combo Of RT And Chemotherapy: Best For Early FL

Posted on

For the management of early-stage follicular lymphoma (FL), a randomized trial shows that the combination of radiotherapy (RT) with chemo immunotherapy gives better clinical outcomes that treatment with radiation alone, and the researchers reporting these results say that they should change clinical practice. After a median follow-up of 9.6 years, the estimated 10-year progression-free survival…

Read more

Posted on

Drug Combination Shows Promise In Advanced Prostrate Cancer.

Posted on

Adding the poly ADP ribose polymerase (PARP) inhibitor olaparib (Lynparza, AstraZeneca) to the androgen synthesis inhibitor abiraterone acetate (Zytiga, Janssen) significantly improves progression-free survival (PFS) in men with advanced prostate cancer over abiraterone alone, UK researchers have discovered. Studying 142 patients with metastatic castration-resistant prostate cancer (mCRPC), Dr Noel Clarke, The Christie and Salford Royal…

Read more

Posted on Leave a comment

You are invited to the 4th anniversary of GDMeds

Posted on Leave a comment

4 years ago, Dr. Liya started her business aim to help her clients, and try her best to make it reliable and affordable. Up to date, she still sticks to this mission and never changes. Furthermore, to serve our clients better, this year, Apr 2018, we move to the new e-platform (GDMeds.com). We hope all…

Read more

Posted on Leave a comment

Next-Gen Sequencing for Lung Cancer: Do It Early, for All of Your Patients

Posted on Leave a comment

Next-Gen Sequencing for Lung Cancer: Do It Early, for All of Your Patients   Author: Mark G. Kris, MD Mark Kris from Memorial Sloan Kettering in New York City, talking, once again, about the benefits of doing next-generation sequencing (NGS) at diagnosis on persons with lung cancer. We’ve talked before about the need to get this…

Read more

Posted on Leave a comment

Uveal Melanoma: Better Survival With Liver Directed Therapy.

Posted on Leave a comment

  For patients with uveal melanoma, the most common eye cancer in adults, survival outcomes have improved in recent years, after treatment modalities shifted from systemic to liver-directed therapies. The finding comes from researchers at the Thomas Jefferson University in Philadelphia, Pennsylvania, and was presented at the recent American Society of Clinical Oncology (ASCO) 2018…

Read more